Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.

Etzerodt A, Tsalkitzi K, Maniecki M, Damsky W, Delfini M, Baudoin E, Moulin M, Bosenberg M, Graversen JH, Auphan-Anezin N, Moestrup SK, Lawrence T.

J Exp Med. 2019 Oct 7;216(10):2394-2411. doi: 10.1084/jem.20182124. Epub 2019 Aug 2.

PMID:
31375534
2.

Effect of injection solutions in the dispersion of syringe lubricant (silicone oil).

Lemes BM, Assis de Andrade E, Cruz LS, Minozzo BR, Carey WD, Damsky W, Miot HA, Beltrame FL, Wambier CG.

J Am Acad Dermatol. 2019 Jul 29. pii: S0190-9622(19)32460-0. doi: 10.1016/j.jaad.2019.07.069. [Epub ahead of print] No abstract available.

PMID:
31369770
3.

B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors.

Damsky W, Jilaveanu L, Turner N, Perry C, Zito C, Tomayko M, Leventhal J, Herold K, Meffre E, Bosenberg M, Kluger HM.

J Immunother Cancer. 2019 Jun 14;7(1):153. doi: 10.1186/s40425-019-0613-1.

4.

Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.

Damsky W, Thakral D, McGeary MK, Leventhal J, Galan A, King B.

J Am Acad Dermatol. 2019 Jun 8. pii: S0190-9622(19)30903-X. doi: 10.1016/j.jaad.2019.05.098. [Epub ahead of print]

PMID:
31185230
5.

Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies-Taming T REX.

Damsky W, King BA.

JAMA Dermatol. 2019 Mar 1;155(3):283-284. doi: 10.1001/jamadermatol.2018.4836. No abstract available.

PMID:
30673073
6.

Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis.

Damsky W, Thakral D, Emeagwali N, Galan A, King B.

N Engl J Med. 2018 Dec 27;379(26):2540-2546. doi: 10.1056/NEJMoa1805958.

7.

scFTD-seq: freeze-thaw lysis based, portable approach toward highly distributed single-cell 3' mRNA profiling.

Dura B, Choi JY, Zhang K, Damsky W, Thakral D, Bosenberg M, Craft J, Fan R.

Nucleic Acids Res. 2019 Feb 20;47(3):e16. doi: 10.1093/nar/gky1173.

8.

Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.

Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F Jr, Sznol M, Petrylak DP, Fischbach N, Goldberg SB, Decker RH, Stamatouli AM, Hafez N, Glusac EJ, Tomayko MM, Leventhal JS.

J Am Acad Dermatol. 2018 Dec;79(6):1081-1088. doi: 10.1016/j.jaad.2018.07.008. Epub 2018 Jul 17.

PMID:
30025829
9.

Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib.

Kim SR, Charos A, Damsky W, Heald P, Girardi M, King BA.

JAAD Case Rep. 2018 Apr 30;4(5):443-445. doi: 10.1016/j.jdcr.2017.12.003. eCollection 2018 Jun. No abstract available.

10.

Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer.

Wang Y, Nasiri AR, Damsky WE, Perry CJ, Zhang XM, Rabin-Court A, Pollak MN, Shulman GI, Perry RJ.

Cell Rep. 2018 Jul 3;24(1):47-55. doi: 10.1016/j.celrep.2018.06.008.

11.

T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

Neubert NJ, Schmittnaegel M, Bordry N, Nassiri S, Wald N, Martignier C, Tillé L, Homicsko K, Damsky W, Maby-El Hajjami H, Klaman I, Danenberg E, Ioannidou K, Kandalaft L, Coukos G, Hoves S, Ries CH, Fuertes Marraco SA, Foukas PG, De Palma M, Speiser DE.

Sci Transl Med. 2018 Apr 11;10(436). pii: eaan3311. doi: 10.1126/scitranslmed.aan3311.

12.

Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity.

Perry CJ, Muñoz-Rojas AR, Meeth KM, Kellman LN, Amezquita RA, Thakral D, Du VY, Wang JX, Damsky W, Kuhlmann AL, Sher JW, Bosenberg M, Miller-Jensen K, Kaech SM.

J Exp Med. 2018 Mar 5;215(3):877-893. doi: 10.1084/jem.20171435. Epub 2018 Feb 7.

13.

Melanocytic nevi and melanoma: unraveling a complex relationship.

Damsky WE, Bosenberg M.

Oncogene. 2017 Oct 19;36(42):5771-5792. doi: 10.1038/onc.2017.189. Epub 2017 Jun 12. Review.

14.

Keratosis lichenoides chronica successfully treated with isotretinoin and methotrexate.

Li AW, Damsky W, King BA.

JAAD Case Rep. 2017 Apr 14;3(3):205-207. doi: 10.1016/j.jdcr.2017.02.009. eCollection 2017 May. No abstract available.

15.

UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model.

Wang J, Perry CJ, Meeth K, Thakral D, Damsky W, Micevic G, Kaech S, Blenman K, Bosenberg M.

Pigment Cell Melanoma Res. 2017 Jul;30(4):428-435. doi: 10.1111/pcmr.12591. Epub 2017 Jun 8.

16.

JAK inhibitors in dermatology: The promise of a new drug class.

Damsky W, King BA.

J Am Acad Dermatol. 2017 Apr;76(4):736-744. doi: 10.1016/j.jaad.2016.12.005. Epub 2017 Jan 28. Review.

17.

Idiopathic erythema multiforme: Evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinib.

Damsky W, King BA.

JAAD Case Rep. 2016 Dec 7;2(6):502-504. doi: 10.1016/j.jdcr.2016.10.009. eCollection 2016 Nov. No abstract available.

18.

Development of bullous pemphigoid during nivolumab therapy.

Damsky W, Kole L, Tomayko MM.

JAAD Case Rep. 2016 Dec 3;2(6):442-444. eCollection 2016 Nov. No abstract available.

19.

STATing the obvious: it's time for new treatments in atopic dermatitis.

Damsky W, King BA.

Br J Dermatol. 2016 Nov;175(5):861-862. doi: 10.1111/bjd.15036. No abstract available.

PMID:
27790697
20.

Painless Vesicular Eruption on the Dorsal Surfaces of the Hands.

Shih A, Damsky W, Zubek A.

JAMA. 2016 Sep 27;316(12):1312-3. doi: 10.1001/jama.2016.11260. No abstract available.

PMID:
27673309
21.

The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations.

Meeth K, Wang JX, Micevic G, Damsky W, Bosenberg MW.

Pigment Cell Melanoma Res. 2016 Sep;29(5):590-7. doi: 10.1111/pcmr.12498. Epub 2016 Aug 3.

22.

Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.

Damsky WE, Choi J.

Curr Treat Options Oncol. 2016 Jul;17(7):33. doi: 10.1007/s11864-016-0410-8. Review.

PMID:
27262707
23.

Revisiting histopathologic findings in Goltz syndrome.

Ko CJ, Antaya RJ, Zubek A, Craiglow B, Damsky W, Galan A, McNiff JM.

J Cutan Pathol. 2016 May;43(5):418-21. doi: 10.1111/cup.12699. Epub 2016 Apr 5.

PMID:
26956940
24.

DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.

Micevic G, Muthusamy V, Damsky W, Theodosakis N, Liu X, Meeth K, Wingrove E, Santhanakrishnan M, Bosenberg M.

Cell Rep. 2016 Mar 8;14(9):2180-2192. doi: 10.1016/j.celrep.2016.02.010. Epub 2016 Feb 25.

25.

Recurrent Coxsackievirus Infection in a Patient with Lamellar Ichthyosis.

Damsky WE, Leventhal JS, Khalil D, Vesely MD, Craiglow BG, Milstone LM, Choate KA.

Pediatr Dermatol. 2016 Mar-Apr;33(2):e140-2. doi: 10.1111/pde.12769. Epub 2016 Jan 29.

PMID:
26821985
26.

A Discordant Cutaneous Eruption in a Neonatal Twin.

Damsky WE, Craiglow BG, Choi J.

JAMA Dermatol. 2016 Apr;152(4):463-4. doi: 10.1001/jamadermatol.2015.5050. No abstract available.

PMID:
26791600
27.

mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.

Damsky W, Micevic G, Meeth K, Muthusamy V, Curley DP, Santhanakrishnan M, Erdelyi I, Platt JT, Huang L, Theodosakis N, Zaidi MR, Tighe S, Davies MA, Dankort D, McMahon M, Merlino G, Bardeesy N, Bosenberg M.

Cancer Cell. 2015 Jan 12;27(1):41-56. doi: 10.1016/j.ccell.2014.11.014.

28.

Melanoma metastasis: new concepts and evolving paradigms.

Damsky WE, Theodosakis N, Bosenberg M.

Oncogene. 2014 May 8;33(19):2413-22. doi: 10.1038/onc.2013.194. Epub 2013 Jun 3. Review.

PMID:
23728340
29.

From bedding to bedside: genetically engineered mouse models of cancer inform concurrent clinical trials.

Damsky WE, Bosenberg M.

Pigment Cell Melanoma Res. 2012 Jul;25(4):404-5. doi: 10.1111/j.1755-148X.2012.01013.x. No abstract available.

PMID:
22578163
30.

β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.

Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE, Taketo MM, Dankort D, Rimm DL, McMahon M, Bosenberg M.

Cancer Cell. 2011 Dec 13;20(6):741-54. doi: 10.1016/j.ccr.2011.10.030.

31.

Unwelcome guests: macrophages promote UV-induced melanoma.

Damsky WE, Bosenberg M.

Pigment Cell Melanoma Res. 2011 Apr;24(2):265-7. No abstract available.

PMID:
21513010
32.

Mouse melanoma models and cell lines.

Damsky WE Jr, Bosenberg M.

Pigment Cell Melanoma Res. 2010 Dec;23(6):853-9. doi: 10.1111/j.1755-148X.2010.00777.x. No abstract available.

PMID:
20973935
33.

Decoding melanoma metastasis.

Damsky WE, Rosenbaum LE, Bosenberg M.

Cancers (Basel). 2010 Dec 30;3(1):126-63. doi: 10.3390/cancers3010126.

34.

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr, You MJ, DePinho RA, McMahon M, Bosenberg M.

Nat Genet. 2009 May;41(5):544-52. doi: 10.1038/ng.356. Epub 2009 Mar 12.

35.

Public awareness of mercury in fish: analysis of public awareness and assessment of fish consumption in vermont.

Damsky WE, Duncan E, Flanagan N, Fromhold K, Dung H, Meyer R, Sax J, Delaney T, Bress W, Hoffman-Contois R, Carney JK.

Mcgill J Med. 2009 Nov 16;12(2):39.

36.

Infection of New- and Old-World Aedes albopictus (Diptera: Culicidae) by the intracellular parasite Wolbachia: implications for host mitochondrial DNA evolution.

Armbruster P, Damsky WE Jr, Giordano R, Birungi J, Munstermann LE, Conn JE.

J Med Entomol. 2003 May;40(3):356-60.

PMID:
12943116

Supplemental Content

Loading ...
Support Center